Enfusion, Inc. (ENFN) · page 29 of 30
The table highlights that Enfusion's EV/EBITDA multiples (28.1x 2024E) are significantly higher than the peer average (14.4x), despite lower EBITDA margins.
Research note · peer_benchmark · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 4/6
callout 1/2 metric 0/1 source-note 1/1 table 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 6
primary callout primary source-note data headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1